TP53 and breast cancer: Inhibiting topoisomerases to interfere with DNA replication via chemotherapeutic drugs such as quinacrine and doxorubicin (DOX, or adriamycin) can cause cell cycle arrest and DNA damage, and induce p53 expression or interfere with DNA damage repair pathways [94,95], thereby leading to apoptosis in BC cells.